SAGE THERAPEUTICS INC

CUSIP: 78667J108 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2021
Shares 115,000 Value ($000) $4,974 Avg Close — Range —
Q3 2021
Shares 115,000 Value ($000) $5,096 Avg Close — Range —
Q2 2021
Shares 75,000 Value ($000) $4,261 Avg Close — Range —
Q1 2020
Shares 50,000 Value ($000) $1,436 Avg Close — Range —
Q4 2019
Shares 50,000 Value ($000) $3,610 Avg Close — Range —
Q3 2019
Shares 20,000 Value ($000) $2,806 Avg Close — Range —
Q2 2019
Shares 21,639 Value ($000) $3,962 Avg Close — Range —
Q1 2019
Shares 51,639 Value ($000) $8,213 Avg Close — Range —
Q4 2018
Shares 137,339 Value ($000) $13,156 Avg Close — Range —
Q3 2018
Shares 124,739 Value ($000) $17,619 Avg Close — Range —
Q2 2018
Shares 129,679 Value ($000) $20,299 Avg Close — Range —
Q1 2018
Shares 95,000 Value ($000) $15,302 Avg Close — Range —
Q4 2017
Shares 104,930 Value ($000) $17,283 Avg Close — Range —
Q3 2017
Shares 50,000 Value ($000) $3,115 Avg Close — Range —
Q2 2017
Shares 50,000 Value ($000) $3,982 Avg Close — Range —
Q1 2017
Shares 72,659 Value ($000) $5,164 Avg Close — Range —